Slingshot Insights
Contributor since: 2016
Company: Slingshot Insights
Latest Articles
Conversation With An Expert: Evaluating Potential Growth Prospects For Keryx's Auryxia
Q2 2018 Biotech Catalyst Watchlist: Phase 2 Clinical Trials
Q2 2018 Biotech Catalyst Watchlist: Phase 3 Clinical Trials
Upcoming Conversation With An Expert: Understanding Bellicum's BPX-501 Potential In The Transplant Setting
Upcoming Conversation With An Expert: Digging Into The Results From Clearside's P3 PEACHTREE Trial
Upcoming Conversation With An Expert: Preparing For More Phase 2 Data From Selecta Biosciences
Amazon Doing What It Does Best - Slingshot Insights' Joe McCann's Idea Of The Month
How Proteostasis' Recent Data In Cystic Fibrosis Compares To Vertex's
Biotech: The Tide Is Turning
Upcoming Conversation With An Expert: What's The Potential Of Global Blood Therapeutics' Voxelotor (GBT440) In Sickle Cell Disease After Data Released At ASH 2017
Upcoming Conversation With An Expert: Highlights In CAR-T
Upcoming Conversation With An Expert: Understanding The Potential Of Lexicon's Sotagliflozin As A Novel Treatment For Diabetes
Conversation With An Expert: Discussing Dynavax's Heplisav-B Vaccine And Market Potential Post-Approval
Conversation With An Expert: Understanding Chiasma's Mycapssa For Acromegaly Patients
An Upcoming Conversation With An Expert: The U.S. Launch Of Exondys 51 For DMD
Understanding Aducanumab's Potential In Alzheimer's
Juno Therapeutics Back With New Data - Slingshot Insights' Idea Of The Month
An Upcoming Conversation With An Expert: Exploring Kala's MPP Technology And The Market Potential For KPI-121 In Dry Eye And Post-Surgical Pain
An Upcoming Conversation With An Expert: Preparing For Revance Therapeutics' Phase 3 Pivotal Trial Data Releases In Q4 2017
Q4 Biotech Catalyst Watchlist
CAR-T Therapy FDA Approved - Slingshot Insights' Idea Of The Month
An Upcoming Discussion With A Cardiologist On Amarin's Vascepa And Its Potential In Treating Hypertriglyceridemia
An Endocrinologist Explains Her View Of Tymlos And The Osteoporosis Landscape
Why Keeping Up With FDA Approvals Could Help Your Stock Portfolio - Slingshot Insights' Joe McCann's Idea Of The Month
Q3 Biotech Catalyst Watch: Key PDUFAs (Part 3)
An Upcoming Conversation With A Cardiologist On The Market Potential For Aralez Pharma's Zontivity And Yosprala
Q3 Biotech Catalyst Watch: Phase 3 Data Releases (Part 2)
Q3 Biotech Catalyst Watch: Phase 2 Data Releases (Part 1)
An Upcoming Conversation With An Expert: Understanding Osteoporosis And Treatment With TYMLOS, Plus ACTIVExtend Results
An Upcoming Conversation With An Expert: Understanding Chronic, Refractory Gout And Treatment With Recombinant Uricase
An Expert's View On New CNS Drugs Including Esketamine, SAGE-547, And SAGE-217 In PPD And MDD
A Conversation With A Nephrologist To Understand The Chances Of Approval And Market Potential Of FGEN's Roxadustat And AKBA's Vadadustat For Anemia In Chronic Kidney Disease